Skip to main content
Signal8
Ferguson Toby profile photo

Toby Ferguson

CIK: 0002015616

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (50.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Voyager Therapeutics, Inc. logo
VYGR

Voyager Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • Voyager Therapeutics, Inc. logo
    VYGR

    Voyager Therapeutics, Inc.

    Feb 6, 2026
    Award(A)
    Direct
    45K shares-
  • Voyager Therapeutics, Inc. logo
    VYGR

    Voyager Therapeutics, Inc.

    Aug 18, 2025
    Sale(S)
    Direct
    19K shares at avg. $3.73$71K
  • Voyager Therapeutics, Inc. logo
    VYGR

    Voyager Therapeutics, Inc.

    Apr 2, 2025
    Sale(S)
    Direct
    10.1K shares at avg. $3.43$35K
  • Voyager Therapeutics, Inc. logo
    VYGR

    Voyager Therapeutics, Inc.

    Feb 21, 2025
    Award(A)
    Direct
    63K shares-

1-4 of 4

About Ferguson Toby

Ferguson Toby (SEC CIK 0002015616) files insider reports with the SEC as Chief Medical Officer of Voyager Therapeutics, Inc. (VYGR).

Signal8 holds 4 ownership filings by Ferguson Toby, all Form 4s, filed between Feb 24, 2025 and Feb 10, 2026. Those filings report 4 transactions, from Feb 21, 2025 to Feb 6, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Ferguson Toby's filings is in LEXINGTON, MA.

Recent filings by Ferguson Toby

  • Feb 6, 2026: Grant or award of VYGR shares (Form 4, code A).
  • Aug 18, 2025: Open-market sale of VYGR shares (Form 4, code S).
  • Apr 2, 2025: Open-market sale of VYGR shares (Form 4, code S).
  • Feb 21, 2025: Grant or award of VYGR shares (Form 4, code A).

Other insiders filing for Voyager Therapeutics, Inc. (VYGR)

How to read Form 4 transaction codes